Stay updated on Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.

Latest updates to the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry (151) dated 2026-08-28 adds Study Status, Contacts/Locations, Outcome Measures, and Study Design to the record history and updates the revision to v3.6.6. The history also removes the 2025-12-24 entry for Revision: v3.6.5.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRecord History now reflects an updated page version, with Revision: v3.6.5 listed instead of v3.6.4. This indicates the study record has been refreshed to a new version in ClinicalTrials.gov.SummaryDifference0.0%

- Check45 days agoChange DetectedThe footer shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a new site update in the page's revision history.SummaryDifference0.0%

- Check66 days agoChange DetectedA new revision tag v3.6.3 is added to the history and the v3.6.2 entry is removed. This reflects a minor update to the page version in the study record history and does not change the underlying study data or content shown to users.SummaryDifference0.0%

- Check73 days agoChange DetectedThe record history now shows a newer revision entry (v3.6.2). The older revision (v3.6.0) has been removed from the list.SummaryDifference0.0%

- Check88 days agoChange DetectedRecruitment status changed to 'no longer looking for participants.' The record revision was updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.1%

Stay in the know with updates to Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine Safety Extension in Prior Recipients Clinical Trial page.